IPO filing research

Clinuvel Pharmaceuticals Ltd

American Depositary Receipts

follow-on amended DRS/A

Clinuvel Pharmaceuticals Ltd IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: DRS/A on 2026-04-17.

Filing Timeline

SEC EDGAR

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS/A filing.

2026-04-17 · 0001493152-26-017918

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS/A filing.

2026-03-30 · 0001493152-26-013401

DRS/A amended

Amended draft registration statement

Updated draft registration filed before the public launch.

Updates the prior DRS filing.

2026-03-04 · 0001493152-26-008796

DRS filed

Draft registration statement

Draft registration filed confidentially before the public launch.

Begins the tracked draft filing sequence after EFFECT.

2025-12-18 · 0001493152-25-028243

EFFECT effective

SEC effectiveness notice

SEC declared the registration statement effective, allowing the offering to proceed.

Follows 424B3 and marks the registration effective.

2021-08-16 · 9999999995-21-003223

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

Follows 424B3 and confirms the priced prospectus.

American Depositary Share · Flags adr

The current 424B3 filing updates the American Depositary Receipt (ADR) structure for Clinuvel Pharmaceuticals Ltd, effective November 26, 2010. It reflects a change in the ratio of ordinary shares represented by one ADR, adjusting from 10 shares to 1 share. This follows a prior 2006 filing that documented the company's name change from Epitan Limited to Clinuvel Pharmaceuticals Limited.

2010-11-26 · 0001201935-10-000066

424B3 priced

Final prospectus

Final prospectus filed near launch with final deal terms.

First tracked pre-IPO filing for this issuer.

Ordinary Shares · Each American Depositary Share represents ten ordinary shares · Use of proceeds Update to reflect company name change and prospectus details · Flags adr, foreign_private_issuer

The filing is a prospectus under Rule 424(b)(3) for Clinuvel Pharmaceuticals Ltd, reflecting the name change from Epitan Limited to Clinuvel Pharmaceuticals Limited. The effective date of the name change was March 3, 2006. The Bank of New York serves as the depositary for American Depositary Receipts (ADRs) representing the company's shares.

2006-03-20 · 0001201935-06-000018

Comparable Deals

Not enough completed IPOs with similar characteristics to show comparables yet.

Recent News

No recent news stored for this issuer.